EUVIMEDEUVIMED entdecken
Open Access

Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats.

Shailesh N Khatri, Safiyah Sadek, Percell T Kendrick, Emma O Bondy iD, Mei Hong, Sally Pauss, Dan Luo, Thomas E Prisinzano, Kelly E Dunn, Julie A Marusich iD, Joshua S Beckmann, Terry D Hinds und 1 weitere

Experimental and Clinical Psychopharmacology · 2024-04 · 32 (2) · 150-157

DOI: 10.1037/pha0000670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Psychopharmacology, 2024-04. Verfasst von Shailesh N Khatri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Nutritional Sciences, University of Kentucky. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Drug Overdose. Die Arbeit wurde bisher 40-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Withdrawal SyndromeDrug OverdoseRatsMaleFemaleAnimalsNaloxoneFentanylXylazineNarcotic AntagonistsMorphineAnalgesics, Opioid

Substanzen

NaloxoneFentanylXylazineNarcotic AntagonistsMorphineAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pharmacology and Nutritional Sciences, University of Kentucky.
  • Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky.
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University.
  • Center for Drug Discovery, RTI International.
  • Department of Psychology, University of Kentucky.

ORCID-Profile: Emma O Bondy, Julie A Marusich, Cassandra D Gipson

Förderung

  • NIDA NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Kentucky Medical Services Foundation

Zitieren

APA

Khatri, S. N., Sadek, S., Kendrick, P. T., Bondy, E. O., Hong, M., Pauss, S., Luo, D., Prisinzano, T. E., Dunn, K. E., Marusich, J. A., Beckmann, J. S., Hinds, T. D., & Gipson, C. D. (2024). Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats. Experimental and Clinical Psychopharmacology, 32(2), 150-157. https://doi.org/10.1037/pha0000670

Vancouver

Khatri SN, Sadek S, Kendrick PT, Bondy EO, Hong M, Pauss S, et al. Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats. Experimental and Clinical Psychopharmacology. 2024;32(2):150-157. doi:10.1037/pha0000670

BibTeX
@article{Khatri2024,
  author = {Khatri, Shailesh N and Sadek, Safiyah and Kendrick, Percell T and Bondy, Emma O and Hong, Mei and Pauss, Sally and Luo, Dan and Prisinzano, Thomas E and Dunn, Kelly E and Marusich, Julie A and Beckmann, Joshua S and Hinds, Terry D and Gipson, Cassandra D},
  title = {Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2024},
  volume = {32},
  number = {2},
  pages = {150--157},
  doi = {10.1037/pha0000670}
}
Kostenlos starten →